CSU spinoff VetDC uses human drug research to bolster canine cancer-fighting market

CSU spinoff VetDC uses human drug research to bolster canine cancer-fighting market

Startup employs reverse engineering to develop canine cancer product By Phil Lindeman InnovatioNews.com FORT COLLINS -- At VetDC -- a fast-rising Fort Collins-based biotech... Read More

By: Phil Lindeman Friday November 23, 2012 0 comments Tags: canine cancer, CSU Ventures, Fort Collins, Gilead Sciences, Steven Roy, Terry Opgenorth, VetDC